HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Genitourinary chlamydia infection — Clinical Guidelines

Overview

Genitourinary chlamydia infection primarily affects the urethra in men and both the cervix and urethra in women, causing urethritis, cervicitis, and potentially ascending infections leading to complications like pelvic inflammatory disease. 20 24

Diagnosis

Clinical Symptoms: Dysuria, urethral discharge, cervicitis symptoms, and occasionally lower abdominal pain. 24

Nucleic Acid Amplification Tests (NAATs): Highly sensitive and specific for detecting Chlamydia trachomatis DNA from urine or endocervical/urethral swabs. 20

Culture: Less commonly used due to longer turnaround time but remains a gold standard for confirmation. 20

Gram Stain: Useful in urethral discharge but lacks specificity for Chlamydia alone. 20

Management

First-Line Treatment:

- Doxycycline: 100 mg orally twice daily for 7 days. 20 - Azithromycin: 1 g orally as a single dose or 100 mg daily for 3 days. 20

Partner Notification and Treatment: Essential to prevent reinfection and further spread. 20

Follow-Up Testing: Recommended 3 months post-treatment to ensure cure, especially in high-risk populations. 20

Special Populations

Pregnancy: Azithromycin is preferred over doxycycline due to safety concerns with tetracyclines in pregnancy. 20

Pediatrics: NAATs are effective but dosing of antibiotics should be adjusted based on weight; pediatric formulations are crucial. 20

Elderly: No specific differences in management, but comorbidities may influence choice of antibiotics and monitoring for side effects. 20

Key Recommendations

Use nucleic acid amplification tests (NAATs) for accurate diagnosis of Chlamydia trachomatis infections. (Evidence: Strong 20)

Recommend doxycycline 100 mg twice daily for 7 days or azithromycin 1 g as a single dose for first-line treatment in non-pregnant adults. (Evidence: Strong 20)

Implement partner notification and treatment to reduce reinfection rates. (Evidence: Moderate 20)

Conduct follow-up testing 3 months post-treatment to confirm cure, particularly in high-risk groups. (Evidence: Moderate 20)

Prefer azithromycin over doxycycline in pregnant women due to safety considerations. (Evidence: Moderate 20)

References

1 Ahmadi Shilanabad H, Naghdi Sedeh N, Mostafaei H, Mohammadrahimi M, Salehi-Pourmehr H, Hajebrahimi S. Mapping the landscape of uro-oncology research: A scientometric analysis of systematic reviews and meta-analyses (2020-2025). Urologia 2026. link 2 Silberzweig A, Moyer A, Beland L, Kreshover J. Teaching the Male Genitourinary Examination to Internal Medicine Residents: Urology-Led Didactics Improve Confidence in Skills and Likelihood of Examination. The clinical teacher 2026. link 3 Patel AU, Parwani AV, Satturwar S. Artificial intelligence in genitourinary pathology. Histopathology 2026. link 4 Sherrard J, Shanks C, Foley E. Genitourinary medicine consultant workforce in England 2023 - establishing the true numbers. International journal of STD & AIDS 2024. link 5 Rodrigo-Aliaga M, Bosquet-Sanz M, Barrios-Arnau L, Sánchez-Llopis A, Ponce-Blasco P, Monsonís-Usó R et al.. Development and implementation of an immunotherapy unit in a urology department. Actas urologicas espanolas 2023. link 6 Alexandrou M, Driva TS, Makri S, Nikolakea M, Routsi E, Spyrou N et al.. Gender disparity trends in genitourinary oncology academic publishing over the past 3 decades: A bibliometric analysis. Urologic oncology 2023. link 7 Koti M, Robert Siemens D. Sex and Gender Differences in Cancers of the Genitourinary Tract: The Need to Consider Immune Divergence. European urology 2022. link 8 Bögemann M. [Systematic action-Emergencies in systemic cancer therapy!]. Urologie (Heidelberg, Germany) 2022. link 9 Glick H, Sarin A, Herrel LA, Ma L, Moore M, Van Wieren I et al.. Delayed urologic cancer care in the COVID-19 pandemic: Patients' experiences. European journal of cancer care 2022. link 10 Checcucci E, Autorino R, Cacciamani GE, Amparore D, De Cillis S, Piana A et al.. Artificial intelligence and neural networks in urology: current clinical applications. Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2020. link 11 Ambrosini F, Di Stasio A, Mantica G, Cavallone B, Serao A. COVID-19 pandemic and uro-oncology follow-up: A "virtual" multidisciplinary team strategy and patients' satisfaction assessment. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 2020. link 12 Rodler S, Apfelbeck M, Schulz GB, Ivanova T, Buchner A, Staehler M et al.. Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?. European urology focus 2020. link 13 Porpiglia F, Amparore D, Checcucci E, Autorino R, Manfredi M, Iannizzi G et al.. Current Use of Three-dimensional Model Technology in Urology: A Road Map for Personalised Surgical Planning. European urology focus 2018. link 14 Gallagher SA, Smith AB, Matthews JE, Potter CW, Woods ME, Raynor M et al.. Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database--UNC GOLD. Urologic oncology 2014. link 15 Sakshaug JW, Miller DC, Hollenbeck BK, Wei JT, Hollingsworth JM. Urologists and the patient centered medical home. The Journal of urology 2013. link 16 Bailey HR, Mullan H, Pinsent S, Sashidharan PN, Theobald N. Non-consultant career grade doctors in genitourinary medicine - are they up to the job? National survey 2007. International journal of STD & AIDS 2009. link 17 Saad F. New research findings on zoledronic acid: survival, pain, and anti-tumour effects. Cancer treatment reviews 2008. link 18 Robinson AJ, Payne N, Ward H. Public health training in genitourinary medicine. Sexually transmitted infections 2006. link 19 Coyne KM, Maw R, Rooney G, Cohen C. Mentoring in genitourinary medicine. International journal of STD & AIDS 2006. link 20 Corneli HM. Nucleic acid amplification tests (polymerase chain reaction, ligase chain reaction) for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in pediatric emergency medicine. Pediatric emergency care 2005. link 21 Chandramani S, Challenor R, Mehta S. A survey of study leave entitlement in 2002 amongst non-consultant career grade doctors in genitourinary medicine. International journal of STD & AIDS 2004. link 22 Hiscock T. Many hands make light work. International journal of STD & AIDS 1999. link 23 Kawamura N, Nakajima N, Hoshino H, Tanaka M, Koinuma A. Effect of ofloxacin in the treatment of genitourinary tract infection with Ureaplasma urealyticum. Hinyokika kiyo. Acta urologica Japonica 1989. link 24 Johnson LW, Heth WL. Infections of the male genitourinary system. Primary care 1989. link 25 Clark R, Cardona L, Valainis G, Hanna B. Genitourinary infections caused by mycobacteria other than Mycobacterium tuberculosis. Tubercle 1989. link90025-1) 26 Timpka T, Bjurulf P. The semantics of diagnosis and management of genitourinary infections: a cross-specialty study. Family practice 1989. link 27 Dieckmann KP, Nekarda H. Triple malignancy of the genitourinary tract. International urology and nephrology 1988. link 28 Boechat MI, Kangarloo H. MR imaging in Drash syndrome. Journal of computer assisted tomography 1988. link 29 Soloway MS, Ikard M, Tidwell M. Role of nurse clinician in urologic oncology. Urology 1978. link90432-6) 30 Schirmer HK. Spontaneous regression of genitourinary cancers. National Cancer Institute monograph 1976. link

Genitourinary chlamydia infection